{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:27:49Z","timestamp":1793410069769,"version":"4.5.0"},"reference-count":44,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["71910107004"],"award-info":[{"award-number":["71910107004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Science and Technology Project of Public Health in Tianjin","award":["21ZXGWSY00090"],"award-info":[{"award-number":["21ZXGWSY00090"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2023,11,8]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Although lung function measures are associated with cardiovascular disease (CVD), the added predictive values of these measures remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From the UK Biobank, 308\u2009415 participants free of CVD with spirometry parameters were included. The CVD outcomes included were defined by QRISK3, the American College of Cardiology\/American Heart Association (ACC\/AHA) and the European Systematic Coronary Risk Evaluation (SCORE) prediction models, respectively. Cox proportional hazard models were used to estimate the associations of lung function measures with CVD outcomes. The predictive capability was determined by the decision curve analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Over a median follow-up of 12.5 years, 21\u2009885 QRISK3 events, 12\u2009843 ACC\/AHA events and 2987 SCORE events were recorded. The associations of spirometry parameters with CVD outcomes were L-shaped. Restrictive and obstructive impairments were associated with adjusted HRs of 1.84 (95% CI: 1.65 to 2.06) and 1.72 (95% CI: 1.55 to 1.90) for SCORE CVD, respectively, compared with normal spirometry. Similar associations were seen for QRISK3 CVD (restrictive vs normal, adjusted HR: 1.30, 95% CI: 1.25 to 1.36; obstructive vs normal, adjusted HR: 1.20, 95% CI: 1.15 to 1.25) and ACC\/AHA CVD (restrictive vs normal, adjusted HR: 1.39, 95% CI: 1.31 to 1.47; obstructive vs normal, adjusted HR: 1.26, 95% CI: 1.19 to 1.33). Using models that integrated non-linear forced expiratory volume in 1\u2009s led to additional 10-year net benefits per 100\u2009000 persons of 25, 43 and 5 for QRISK3 CVD at the threshold of 10%, ACC\/AHA CVD at 7.5% and SCORE CVD at 5.0%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Clinicians could consider spirometry indicators in CVD risk assessment. Cost-effectiveness studies and clinical trials are needed to put new CVD risk assessment into practice.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thorax-2023-220703","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T18:21:14Z","timestamp":1700850074000},"page":"250-258","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Predictive value of lung function measures for cardiovascular risk: a large prospective cohort study"],"prefix":"10.1136","volume":"79","author":[{"given":"Lihui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7325-0663","authenticated-orcid":false,"given":"Yaogang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"2024032819551184000_79.3.250.1","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/jch.14364","article-title":"Relationship between lung function impairment, hypertension, and major adverse cardiovascular events: a 10-year follow-up study","volume":"23","author":"Wang","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2024032819551184000_79.3.250.2","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/eurheartj\/ehac205","article-title":"Lung function impairment and risk of incident heart failure: the NHLBI pooled cohorts study","volume":"43","author":"Eckhardt","year":"2022","journal-title":"Eur Heart J"},{"key":"2024032819551184000_79.3.250.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-022-01939-5","article-title":"Restricted spirometry and cardiometabolic comorbidities: results from the international population based BOLD study","volume":"23","author":"Kulbacka-Ortiz","year":"2022","journal-title":"Respir Res"},{"key":"2024032819551184000_79.3.250.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-018-0920-y","article-title":"Association of lung function with cardiovascular risk: a cohort study","volume":"19","author":"Wang","year":"2018","journal-title":"Respir Res"},{"key":"2024032819551184000_79.3.250.5","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206724"},{"key":"2024032819551184000_79.3.250.6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03196-2020","article-title":"Lung function and cardiovascular disease: a two-sample mendelian randomisation study","volume":"58","author":"Higbee","year":"2021","journal-title":"Eur Respir J"},{"key":"2024032819551184000_79.3.250.7","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215600"},{"key":"2024032819551184000_79.3.250.8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019","volume":"53","author":"Singh","year":"2019","journal-title":"Eur Respir J"},{"key":"2024032819551184000_79.3.250.9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212148"},{"key":"2024032819551184000_79.3.250.10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(21)00174-0","article-title":"3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study","volume":"9","author":"Wu","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024032819551184000_79.3.250.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02158-7"},{"key":"2024032819551184000_79.3.250.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"2024032819551184000_79.3.250.13","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000437741.48606.98"},{"key":"2024032819551184000_79.3.250.14","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"Hageman","year":"2021","journal-title":"Eur Heart J"},{"key":"2024032819551184000_79.3.250.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0579-z"},{"key":"2024032819551184000_79.3.250.16","unstructured":"UK Biobank . First occurrence of health outcomes defined by 3-character ICD10 code. 2019. Available: https:\/\/biobank.ndph.ox.ac.uk\/ukb\/ukb\/docs\/first_occurrences_outcomes.pdf [Accessed 01 Feb 2023]."},{"key":"2024032819551184000_79.3.250.17","unstructured":"UK Biobank . Spirometry measurement using ACE. 2011. Available: https:\/\/biobank.ndph.ox.ac.uk\/ukb\/ukb\/docs\/Spirometry.pdf [Accessed 01 Feb 2023]."},{"key":"2024032819551184000_79.3.250.18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02140-2018","article-title":"Air pollution, lung function and COPD: results from the population-based UK biobank study","volume":"54","author":"Doiron","year":"2019","journal-title":"Eur Respir J"},{"key":"2024032819551184000_79.3.250.19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"2024032819551184000_79.3.250.20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201508-1603OC"},{"key":"2024032819551184000_79.3.250.21","unstructured":"European Respiratory Society . Spirometry equation tools - R macro. E-learning resources 2017. 2017. Available: http:\/\/www.ers-education.org\/guidelines\/global-lung-function-initiative\/spirometry-tools\/r-macro.aspx [Accessed 22 Feb 2022]."},{"key":"2024032819551184000_79.3.250.22","unstructured":"Harrell FE . Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York, Inc. New York, USA: Springer-Verlag, 2010."},{"key":"2024032819551184000_79.3.250.23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-2600(21)00369-6","article-title":"Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK biobank cohort analysis","volume":"10","author":"Higbee","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2024032819551184000_79.3.250.24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03320430047030"},{"key":"2024032819551184000_79.3.250.25","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1802"},{"key":"2024032819551184000_79.3.250.26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.672402"},{"key":"2024032819551184000_79.3.250.27","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1177\/0962280214567141","article-title":"Predictive accuracy of novel risk factors and markers: a simulation study of the sensitivity of different performance measures for the cox proportional hazards regression model","volume":"26","author":"Austin","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"2024032819551184000_79.3.250.28","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361"},{"key":"2024032819551184000_79.3.250.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.08.038"},{"key":"2024032819551184000_79.3.250.30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010672","article-title":"Lung function in young adults and risk of cardiovascular events over 29 years: the CARDIA study","volume":"7","author":"Cuttica","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2024032819551184000_79.3.250.31","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023990","article-title":"Association of pulmonary function with late-life cardiac function and heart failure risk: the ARIC study","volume":"11","author":"Ramalho","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2024032819551184000_79.3.250.32","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2147\/COPD.S242809","article-title":"FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease","volume":"15","author":"Bikov","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024032819551184000_79.3.250.33","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213440"},{"key":"2024032819551184000_79.3.250.34","unstructured":"World Health Organization . Coronavirus disease (COVID-19) pandemic. 2023. Available: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019 [Accessed 06 Mar 2023]."},{"key":"2024032819551184000_79.3.250.35","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11112237","article-title":"Overview of the mechanisms of oxidative stress: impact in inflammation of the airway diseases","volume":"11","author":"Albano","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"2024032819551184000_79.3.250.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2015.12.007"},{"key":"2024032819551184000_79.3.250.37","doi-asserted-by":"crossref","first-page":"12696","DOI":"10.3390\/ijms140612696","article-title":"Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on sirtuins","volume":"14","author":"Corbi","year":"2013","journal-title":"Int J Mol Sci"},{"key":"2024032819551184000_79.3.250.38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2796.1994.tb01050.x","article-title":"Haematocrit, hypertension and risk of stroke","volume":"235","author":"Wannamethee","year":"1994","journal-title":"J Intern Med"},{"key":"2024032819551184000_79.3.250.39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1055\/s-0037-1614066","article-title":"Blood rheology, cardiovascular risk factors, and cardiovascular disease: the west of Scotland coronary prevention study","volume":"84","author":"Lowe","year":"2000","journal-title":"Thromb Haemost"},{"key":"2024032819551184000_79.3.250.40","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1683"},{"key":"2024032819551184000_79.3.250.41","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.mayocp.2019.12.032","article-title":"Grip strength and walking pace and cardiovascular disease risk prediction in 406,834 UK biobank participants","volume":"95","author":"Welsh","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"2024032819551184000_79.3.250.42","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1093\/eurjpc\/zwaa063","article-title":"Lipoprotein(A) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions","volume":"28","author":"Welsh","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2024032819551184000_79.3.250.43","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201701-0218PP"},{"key":"2024032819551184000_79.3.250.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.06.049"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2023-220703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T02:56:36Z","timestamp":1711680996000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2023-220703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2,15]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/thorax-2023-220703"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2023-220703","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]}}}